316 related articles for article (PubMed ID: 27889588)
1. Preparation and properties evaluation of a novel pH-sensitive liposomes based on imidazole-modified cholesterol derivatives.
Ju L; Cailin F; Wenlan W; Pinghua Y; Jiayu G; Junbo L
Int J Pharm; 2017 Feb; 518(1-2):213-219. PubMed ID: 27889588
[TBL] [Abstract][Full Text] [Related]
2. Spontaneous vesicle formation by γ-aminobutyric acid derived steroidal surfactant: Curcumin loading, cytotoxicity and cellular uptake studies.
Bajani D; Dey J; Rajesh Y; Bandyopadhyay S; Mandal M
J Colloid Interface Sci; 2017 Dec; 507():1-10. PubMed ID: 28779647
[TBL] [Abstract][Full Text] [Related]
3. Chitooligosaccharides Modified Reduction-Sensitive Liposomes: Enhanced Cytoplasmic Drug Delivery and Osteosarcomas-Tumor Inhibition in Animal Models.
Yin X; Chi Y; Guo C; Feng S; Liu J; Sun K; Wu Z
Pharm Res; 2017 Oct; 34(10):2172-2184. PubMed ID: 28726003
[TBL] [Abstract][Full Text] [Related]
4. Folate-PEG coated cationic modified chitosan--cholesterol liposomes for tumor-targeted drug delivery.
Wang H; Zhao P; Liang X; Gong X; Song T; Niu R; Chang J
Biomaterials; 2010 May; 31(14):4129-38. PubMed ID: 20163853
[TBL] [Abstract][Full Text] [Related]
5. Fusogenic pH sensitive liposomal formulation for rapamycin: improvement of antiproliferative effect.
Ghanbarzadeh S; Khorrami A; Mohamed Khosroshahi L; Arami S
Pharm Biol; 2014 Jul; 52(7):848-54. PubMed ID: 24920230
[TBL] [Abstract][Full Text] [Related]
6. Ethanol-based proliposome delivery systems of paclitaxel for in vitro application against brain cancer cells.
Najlah M; Jain M; Wan KW; Ahmed W; Albed Alhnan M; Phoenix DA; Taylor KMG; Elhissi A
J Liposome Res; 2018 Mar; 28(1):74-85. PubMed ID: 27834116
[TBL] [Abstract][Full Text] [Related]
7. Design and evaluation of pH-sensitive liposomes constructed by poly(2-ethyl-2-oxazoline)-cholesterol hemisuccinate for doxorubicin delivery.
Xu H; Hu M; Yu X; Li Y; Fu Y; Zhou X; Zhang D; Li J
Eur J Pharm Biopharm; 2015 Apr; 91():66-74. PubMed ID: 25660909
[TBL] [Abstract][Full Text] [Related]
8. Cholesterol anchored arabinogalactan for asialoglycoprotein receptor targeting: synthesis, characterization, and proof of concept of hepatospecific delivery.
Pathak PO; Nagarsenker MS; Barhate CR; Padhye SG; Dhawan VV; Bhattacharyya D; Viswanathan CL; Steiniger F; Fahr A
Carbohydr Res; 2015 May; 408():33-43. PubMed ID: 25841057
[TBL] [Abstract][Full Text] [Related]
9. Improvement on stability, loading capacity and sustained release of rhamnolipids modified curcumin liposomes.
Cheng C; Wu Z; McClements DJ; Zou L; Peng S; Zhou W; Liu W
Colloids Surf B Biointerfaces; 2019 Nov; 183():110460. PubMed ID: 31473408
[TBL] [Abstract][Full Text] [Related]
10. Pluronics modified liposomes for curcumin encapsulation: Sustained release, stability and bioaccessibility.
Li ZL; Peng SF; Chen X; Zhu YQ; Zou LQ; Liu W; Liu CM
Food Res Int; 2018 Jun; 108():246-253. PubMed ID: 29735054
[TBL] [Abstract][Full Text] [Related]
11. Development of antiproliferative long-circulating liposomes co-encapsulating doxorubicin and curcumin, through the use of a quality-by-design approach.
Tefas LR; Sylvester B; Tomuta I; Sesarman A; Licarete E; Banciu M; Porfire A
Drug Des Devel Ther; 2017; 11():1605-1621. PubMed ID: 28579758
[TBL] [Abstract][Full Text] [Related]
12. [Preparation of curcumin-loaded long-circulating liposomes and its pharmacokinetics in rats].
You J; Dai DB; He WJ; Li G; Song SC; Wei YH; Li FZ; Xu XL
Zhongguo Zhong Yao Za Zhi; 2014 Apr; 39(7):1238-42. PubMed ID: 25011261
[TBL] [Abstract][Full Text] [Related]
13. Curcumin loaded pH-sensitive hybrid lipid/block copolymer nanosized drug delivery systems.
Jelezova I; Drakalska E; Momekova D; Shalimova N; Momekov G; Konstantinov S; Rangelov S; Pispas S
Eur J Pharm Sci; 2015 Oct; 78():67-78. PubMed ID: 26159739
[TBL] [Abstract][Full Text] [Related]
14. Sustained Release from Ionic-Gradient Liposomes Significantly Decreases ETIDOCAINE Cytotoxicity.
Oliveira JD; Ribeiro LNM; Rodrigues da Silva GH; Casadei BR; Couto VM; Martinez EF; de Paula E
Pharm Res; 2018 Oct; 35(12):229. PubMed ID: 30306273
[TBL] [Abstract][Full Text] [Related]
15. pH-Responsive nanoparticles based on cholesterol/imidazole modified oxidized-starch for targeted anticancer drug delivery.
Xu Y; Zi Y; Lei J; Mo X; Shao Z; Wu Y; Tian Y; Li D; Mu C
Carbohydr Polym; 2020 Apr; 233():115858. PubMed ID: 32059909
[TBL] [Abstract][Full Text] [Related]
16. Phase transition behavior of novel pH-sensitive polyaspartamide derivatives grafted with 1-(3-aminopropyl)imidazole.
Seo K; Kim D
Macromol Biosci; 2006 Sep; 6(9):758-66. PubMed ID: 16967481
[TBL] [Abstract][Full Text] [Related]
17. Preparation and in vitro evaluation of a folate-linked liposomal curcumin formulation.
Lu Y; Ding N; Yang C; Huang L; Liu J; Xiang G
J Liposome Res; 2012 Jun; 22(2):110-9. PubMed ID: 22372871
[TBL] [Abstract][Full Text] [Related]
18. Comb-like amphiphilic copolymers bearing acetal-functionalized backbones with the ability of acid-triggered hydrophobic-to-hydrophilic transition as effective nanocarriers for intracellular release of curcumin.
Zhao J; Wang H; Liu J; Deng L; Liu J; Dong A; Zhang J
Biomacromolecules; 2013 Nov; 14(11):3973-84. PubMed ID: 24107101
[TBL] [Abstract][Full Text] [Related]
19. [Preparation and study in vitro of long-circulating nanoliposomes of curcumin].
Hong W; Chen DW; Zhao XL; Qiao MX; Hu HY
Zhongguo Zhong Yao Za Zhi; 2008 Apr; 33(8):889-92. PubMed ID: 18619344
[TBL] [Abstract][Full Text] [Related]
20. Study of the pH-sensitive mechanism of tumor-targeting liposomes.
Fan Y; Chen C; Huang Y; Zhang F; Lin G
Colloids Surf B Biointerfaces; 2017 Mar; 151():19-25. PubMed ID: 27940165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
